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Abstract 
Brefeldin A is a fungal metabolite which disrupts protein traffic through the Golgi apparatus and thereby inhibits protein secretion. Recently, it 
has been shown that Brefeldin A also causes a marked decrease in the rate of protein synthesis in cells in culture [1992, FEBS Lett. 314, 371-3741. 
We show here that treatment of rat GH3 pituitary cells with Brefeldin A leads to an inhibition of protein synthesis at the level of peptide~hain i itiation 
through a mechanism involving the phosphorylation of the a-subunit of eukaryotic initiation factor-2 (eIF-2a). 
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1. Introduction 
Brefeldin A is a fungal metabolite which causes the 
collapse of the Golgi apparatus into the endoplasmic 
reticulum (ER) resulting in a total inhibition of protein 
secretion [l]. Disassembly of the Golgi apparatus is ac- 
companied by a redistribution of resident Golgi mem- 
brane proteins to the ER [2] and an accumulation of 
incompletely-processed glycoproteins in this compart- 
ment ([3,4], reviewed in [5]). It has recently been shown 
that Brefeldin A has an inhibitory effect on protein syn- 
thesis in a wide variety of cells in culture over the same 
concentration range used to inhibit protein secretion [6]. 
The nature of this inhibition has been unclear. It has 
previously been reported that certain inhibitors of ER- 
processing cause an inhibition of protein synthesis 
through a mechanism involving the phospho~lation of 
the a-subunit of eukaryotic initiation factor-2 (eIF-2a, 
[7] and refs. therein). eIF-2 mediates the binding of the 
initiator tRNA (Met-tRNAJ to the 40s ribosomal sub- 
unit in eukaryotic cells (reviewed in [S]). This reaction is 
dependent on GTP which is hydrolyzed to GDP prior to 
the association of the 60s ribosomal subunit, eIF-2 is 
then released from the ribosome as an inactive complex 
with GDP. The guanine nucleotide-exchange factor eIF- 
2B catalyzes the exchange of GDP for GTP on eIF-2, 
thus regenerating active eIF-2. Phosphorylation of eIF- 
201 at a specific serine residue (Se?‘) impairs this ex- 
change reaction and leads to an inhibition of transla- 
tional initiation [8]. We show here that Brefeldin 
A-treatment of rat GH3 pituitary tumor cells leads to an 
inhibition of protein synthesis at the level of peptide- 
chain initiation in parallel with an increase in eIF-2ol 
phosphorylation and a decrease in eIF-2B activity. 
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2. Materials and methods 
2. I. laterals 
Brefeldin A was obtained from Sigma and was stored as a 5 mg. ml-’ 
solution in ethanol at -20°C. [‘H]GDP and cell-labeling grade 
[“Slmethionine were from Amersham. Ampholytes (BDH-certified Re- 
solyte, pH 4-8) were from Hoeffer Scientific Instruments. 
2.2. Cell culture 
Rat GH3 pituitary tumor cells were grown in culture in Dulbecco’s 
Modified Eagle Medium containing 25 mM HEPES (Life Sciences Inc.) 
suppl~ented with 10% fetal bovine serum (Hyclone Labs. Inc.), 100 
U’ml-’ ~nzylpeni~llin and 100 fig.rnl-’ streptomycin sulfate. 
2.3. Ribosomal subunit analysis 
Cells (approximately 5 x lo6 cells) were washed in ice-cold wash 
buffer (5 mM Tris-HCI, pH 7.4, 1.5 mM KCI, 2.5 mM MgCl,) and 
extracted by a modification of the method of Thomas et al. [9]. The 
washed cells were lysed in 1 ml of ice-cold extraction buffer (50 mM 
Tris-HCI, pH 7.4, 26 mM KCI, 5 mM MgCl,, 1% (w/v) sodium de- 
oxycholate, 1% (v/v) Triton X-100, 1 mM phenylmethylsulfonyl fluo- 
ride, 4 ,ug+ml-’ leupeptin and 4 pg.rnl-’ ~ps~tin~. The extracts were 
then clarified by ~nt~fugation at 10,000 x g for IO min at 4”c and 500 
~1 of each extract was layered anto linear 2047% (w/v) sucrose gradi- 
ents. The gradients were centrifuged at 200,000 x g for 2 h at 4°C. The 
gradients were then analyzed by upward displacement through the 
optical cell of an ISCO 640 density gradient fractionator which re- 
corded the absorbance at 254 nm. 
2.4. Measurement of protein synthesis and eIF-2a phosphorylation 
Cells (approximately 0.5 x IO6 cells) were incubated in culture me- 
dium in the presence or absence of 1 pg.rnl-’ Brefeldin A. For the 
measurement of protein synthesis, cells were incubated in the presence 
of [“S]methionine (approximately 5@Ci. ml-‘). At various time points, 
the culture medium was removed and the cells were washed once with 
1 ml of ice-cold phosphate-buffered saline and then twice with 1 ml of 
ice-cold 10% (w/v) trichloroacetic acid. The acid-washed cell pellets 
were then dissolved in 0.2 M NaOH and the incorporation of radiolabel 
into protein was determined by liquid scintillation counting. For the 
measurement of eIF-2a phospho~lation, cells were extracted in 200@ 
of SDS-PAGE sample buiTer at 90°C. The samples were heated in 90°C 
for 3 min, diluted with 2 ~01s. of isoelectric focusing gel buffer (9.5 M 
urea, 4% (v/v) amphoiytes, 5% (v/v) 2-mercaptoethanol, 8% Nonidet 
P-40) and then adjusted to a final urea concentration of 9.5 M. The 
proportion of phosphorylated eIF-2a was determined by protein im- 
munoblot analysis of slab isoelectric focusing gels using a monoclonal 
antibody to eIF-2a (generously provided by Drs. R. Panniers and E.C. 
Henshaw) according to the protocol of Kimball and Jefferson [lo]. 
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2.5. Measurement of eIF-2B activity 
Cells (approximately 1 x lo6 cells) were incubated in culture medium 
in the presence or absence of 1 pg 'ml-' Brefeldin A for 3 h. The culture 
medium was removed and the cells were washed once with ice-cold 
phosphate-buffered saline and then extracted with 400 ~1 of ice-cold 
extraction buffer (45 mM HEPES, pH 7.4, 0.375 mM magnesium ace- 
tate, 0.075 mM EDTA, 95 mM potassium acetate, 2.5 mg’ml-’ dig- 
itonin and 10% (v/v) glycerol). The extracts were clarified by centrifuga- 
tion at 10,000 x g for 10 min at 4°C and the supernatants were then 
assayed for the exchange of [‘H]GDP bound to eIF-2 for unlabeled 
GTP as previously described [I I]. 
2.6. Quantification of eIF-2 and eIF-2B 
The molar ratio of eIF-2:elF-2B in GH3 cells was determined as 
described [12] by immunoblot analysis of cell extracts using monoclonal 
antibodies against rat elF-2cr and the &-subunit of eIF-2B. Experiments 
were performed in triplicate and the signals were quantitated by com- 
parison with standard samples of purified rat eIF-2 and eIF-2B. 
3. Results 
3.1. Inhibition ofpeptide-chain initiation by Brefeldin A 
We examined the effect of 1 ,ug*ml-’ Brefeldin A on 
the rate of protein synthesis in GH3 cells. This concen- 
tration was chosen because it has been widely used to 
inhibit Golgi function in studies of protein secretion. 
Incubation of GH3 cells in the presence of Brefeldin A 
led to an approximately 33% inhibition of protein syn- 
thesis (Fig. l), a level of inhibition similar to that re- 
ported with other cell-types [6]. Inhibition of protein 
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Fig. 1. Cells were incubated with [‘5S]methionine in the absence (0) or 
presence (0) of 1 pg.rnl-’ Brefeldin A. At the times indicated the 
incorporation of radiolabel into protein was measured as described in 
section 2.4. Data represent the mean f S.E.M. of experiments perfor- 
med in triplicate (the error bars fall within the size of each point). The 
standard error on each data point was < 5%. Cells incubated in the ab- 
sence of Brefeldin A incorporated [“Slmethionine into protein at a rate of 
856 cpm.min-‘. This rate of protein synthesis was matched in cells treat- 
ed with Brefeldin A until approximately 90 min of incubation, when the 
rate of incorporation of radioactivity decreased to 573 cpm’min-‘. 
Sedimentation - 
Fig. 2. Cells were incubated in the absence (Panel A) or presence (Panel 
B) of 1 pg.rnl-’ Brefeldin A for 3 h. The cells were extracted and the 
post-mitochondrial supernatants were analyzed by density-gradient 
centrifugation to examine the state of ribosomal aggregation. The fig- 
ure shows a representative experiment. The positions of the 40s and 60s 
ribosomal subunits and the 80s monomer are indicated. Brefeldin A- 
treatment caused a 48% increase in free 60s ribosomal subunits and 80s 
monomers (average of duplicate experiments). 
synthesis was not observed until 90 min of incubation 
suggesting that this was a consequence of inhibition of 
protein secretion, which occurs over a similar time 
course in these cells [13]. Density gradient analysis of the 
state of ribosomal aggregation in Brefeldin A-treated 
GH3 cells showed that the inhibition of protein synthesis 
occurred at the level of peptide-chain initiation, as indi- 
cated by a marked increase in free ribosomal subunits 
and monomeric ribosomes relative to control cells 
(Fig. 2). 
3.2. Brefeldin A-treatment leads to an increase in eIF-2a 
phosphorylation 
The involvement of eIF-2a phosphorylation in the 
control of protein synthesis by other modulators of ER 
processing prompted us to examine the state of phospho- 
rylation of this initiation factor in Brefeldin A-treated 
cells. Brefeldin A caused a time-dependent increase in 
eIF-2ol phosphoryation which paralleled the inhibition 
of protein synthesis (Fig. 3). Phosphorylation was first 
observed at 60 min and quickly plateaued at a level 
where approximately 25% of the factor was in the 
phosphorylated state (Fig. 3). After 3 h of Bredeldin A 
treatment, when 26% of eIF-2a is phosphorylated, the 
nucleotide-exchange activity of eIF-2B in cell extracts 
(calculated over the time course of linear response) was 
found to be reduced by approximately 41% (Fig. 4). This 
reduction is in reasonable agreement with the effect on 
protein synthesis (33% inhibition) but out of proportion 
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Fig. 3. Cells were incubated in the presence of 1 pg.ml-’ Brefeldin A. 
At the times indicated samples were extracted and the proportion of 
eIF-2a in the phosphorylated state was determined by protein im- 
munoblot analysis of isoelectric focusing slab gels as described in sec- 
tion 2.4. Data represent he mean f S.E.M. of experiments performed 
in triplicate. The inset panels show the immunoblots of the 0 h and 3 
h samples from a representative experiment. 
with the change in eIF-2a phosphorylation. Previous 
studies have used indirect methods to measure the molar 
ratios of eIF-2 : eIF-2B in rabbit reticulocytes (6 : 1, [ 141) 
and Erhlich ascites cells (2 : 1, [ 151) and it has been pro- 
posed that a consequence of these high molar ratios is 
that only a small increase in eIF-2a phosphorylation is 
required to cause a significant inhibition of eIF-2B activ- 
ity [8]. In recent studies, we ([12] and unpublished data) 
and others [16] have directly quantified the amounts of 
eIF-2 and eIF-2B in various tissues and demonstrated 
considerable tissue-specific variation. It is therefore im- 
portant to determine the ratio of eIF-2:eIF-2B in any 
system when evaluating the relevance of changes in eIF- 
2a phosphorylation. We determined the molar ratio of 
eIF-2:eIF-2B in GH3 cells to be 1.3: 1 f 9.4% (S.E.M., 
n = 3, Fig. 5). Brefeldin A-treatment did not effect this 
ratio, nor the cellular level of either factor (data not 
shown). Phosphorylation of 26% of the eIF-201 after 3 h 
of Brefeldin A-treatment would therefore be expected to 
lead to a 34% inhibition of eIF-2B activity and a similar 
degree of inhibition of protein synthesis, in good agree- 
ment with our experimental findings. 
4. Discussion 
In the studies presented here we have shown that the 
inhibition of protein synthesis in Brefeldin A-treated 
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Fig. 4. Cells were incubated in the absence (0) or presence (0) of 1 
,~g.rnl-‘. Brefeldin A for 3 h. The cells were then extracted 
and assayed for eIF-2B activity as described in section 2.5. The figure 
shows the amount of eIF-2. [‘H]GDP complex remaining over a 16 min 
time course. Data represent he average of two experiments. 
GH3 cells occurs at the level of peptide-chain initiation 
and is accompanied by an increase in eIF-2a phosphoryl- 
ation and a decrease in eIF-2B activity. Our studies were 
prompted by research which has shown that eIF-2cx 
phosphorylation increases when the ER is depleted of 
calcium by calcium-mobilizing hormones such as vaso- 
pressin [17] or chemical agents [7,10,18,19], or when the 
redox state of this compartment is altered by treatment 
1 2 3 4 5 6 7 8 9 10 
Fig. 5. The molar ratio of eIF-2 to eIF-2B in GH3 cells was determined 
by immunoblot analysis of cells extracts separated by SDS-PAGE as 
described in section 2.6. Lanes 1-7; 2.4,4.8, 7.2, 9.6, 12, 14.4 and 16.8 
ng of purified eIF-2, respectively and, 8, 16, 24, 32, 40, 48 and 56 ng 
of purified eIF-2B, respectively. Lanes 8-10 contain approximately 14 
pg of cell extract from three separate GH3 cell cultures. The positions 
of the a-subunit of eIF-2 and the s-subunit of eIF-2B are indicated. 
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with dithiothreitol[7]. These conditions lead to an accu- 
mulation of partially-processed and malfolded proteins 
in the ER [7] as does Brefeldin A treatment [3,4]. Inhib- 
itors of glycoprotein processing which do not cause the 
retention of protein by the ER do not trigger eIF-2ol 
phosphorylation or an inhibition of protein synthesis [7]. 
eIF-2 is a cytosolic protein and clearly a mechanism must 
exist to sense an accumulation of protein in the ER and 
communicate this to the cytoplasmic compartment. 
Prostko et al. [7] have suggested that the signal may be 
generated at the site of the paused translocon on the 
exterior face of the ER, however, the nature of this signal 
is obscure. Heme-controlled repressor (HCR) is a serine/ 
threonine protein kinase whose only known substrate is 
eIF-2ol[20]. It has been suggested that this protein kinase 
may be responsible for the increase in eIF-2a phospho- 
rylation observed during heat shock and, in support of 
this hypothesis, it has been shown that HCR is activated 
when denatured protein is added to rabbit reticulocyte 
lysates [21]. HCR may be similarly activated by nascent 
peptide chains frozen at the translocation site on the ER 
by inhibitors of ER-processing. In this case, inhibition 
of protein synthesis would initially be localized to this 
area. This would explain the loss of ribosomes from the 
ER surface seen in Brefeldin A-treated cells [22]. We are 
currently investigating the possible involvement of HCR 
and other eIF-2a kinases in the inhibition of peptide- 
chain initiation caused by Brefeldin A-treatment. 
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